Loop diuretic utilisation with or without heart failure: impact on prognosis

Friday, J. M. et al. (2024) Loop diuretic utilisation with or without heart failure: impact on prognosis. European Heart Journal, (doi: 10.1093/eurheartj/ehae345) (PMID:38845446) (Early Online Publication)

[img] Text
326396.pdf - Accepted Version
Available under License Creative Commons Attribution.

1MB

Abstract

Background and Aims: Many patients are prescribed loop diuretics without a diagnostic record of heart failure. Little is known about their characteristics and prognosis. Methods: Glasgow regional health records (2009-2016) were obtained for adults with cardiovascular disease or taking loop diuretics. Outcomes were investigated using Cox models with hazard ratios adjusted for age, sex, socioeconomic deprivation, and co-morbid disease (adjHR). Results: Of 198,898 patients (median age 65 years; 55% women), 161,935 (81%) neither took loop diuretics nor had a diagnostic record of heart failure (reference group), 23,963 (12%) were taking loop diuretics but had no heart failure recorded, 7,844 (4%) had heart failure recorded and took loop diuretics and 5,156 (3%) had heart failure recorded but were not receiving loop diuretics. Five-year mortality was only slightly higher for heart failure in absence of loop diuretics (22%; adjHR: 1.2 [95% CI 1.1-1.3]), substantially higher for those taking loop diuretics with no heart failure recorded (40%; adjHR: 1.8 [95% CI 1.7-1.8]) and highest for heart failure treated with loop diuretics (52%; adjHR: 2.2 [95% CI 2.0-2.2]). Conclusions: For patients with cardiovascular disease, many are prescribed loop diuretics without a diagnosis of heart failure being recorded. Mortality is more strongly associated with loop diuretic use than with a heart failure record. The diagnosis of heart failure may be often missed, or loop diuretic use is associated with other conditions with a prognosis similar to heart failure, or inappropriate loop diuretic use increases mortality; all might be true.

Item Type:Articles
Additional Information:JMF's PhD funding was provided by the Institute of Health and Wellbeing and the College of Medical, Veterinary, and Life Sciences at the University of Glasgow. JMF, JJVM, JGFC, and PSJ are supported by a British Heart Foundation Centre for Research Excellence Grant (grant number RE/18/6/34217), JJVM and PSJ by the Vera Melrose Heart Failure Research Fund. PP received a Scotland research grant from Heart Research UK (grant number RG2676/18/21).
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Graham, Dr Fraser and Friday, Dr Jocelyn and Jhund, Professor Pardeep and McAllister, Professor David and Wolters, Dr Maria and Lewsey, Professor Jim and Cleland, Professor John and Pellicori, Dr Pierpaolo and McMurray, Professor John and Jones, Yola
Authors: Friday, J. M., Cleland, J., Pellicori, P., Wolters, M., McMurray, J. J.V., Jhund, P. S., Forsyth, P., McAllister, D. A., Graham, F. J., Jones, Y., and Lewsey, J.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > General Practice and Primary Care
College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment
Journal Name:European Heart Journal
Publisher:Oxford University Press (OUP) on behalf of European Society of Cardiology
ISSN:0195-668X
ISSN (Online):1522-9645
Published Online:07 June 2024
Copyright Holders:Copyright © 2024 The Authors
First Published:First published in European Heart Journal 2024
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
303944BHF Centre of ExcellenceColin BerryBritish Heart Foundation (BHF)RE/18/6/34217SCMH - Cardiovascular & Metabolic Health